Lakeshore Biopharma CO Ltd (LSB)

Dec 19, 2024, 9:05 AM EST - 4 weeks ago

LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance

Dec 12, 2024, 7:57 PM EST - 5 weeks ago

LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China

Oct 29, 2024, 8:30 AM EDT - 2 months ago

LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

Oct 25, 2024, 8:30 AM EDT - 3 months ago

LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine

Oct 8, 2024, 8:30 AM EDT - 3 months ago

LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance

Sep 27, 2024, 7:00 AM EDT - 4 months ago

LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation

Sep 10, 2024, 8:00 AM EDT - 4 months ago

Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024

Sep 4, 2024, 8:00 AM EDT - 4 months ago

LakeShore Biopharma Announces Leadership Transitions

Aug 15, 2024, 8:30 AM EDT - 5 months ago

LakeShore Biopharma Announces Financial Results for Fiscal Year 2024

Jul 5, 2024, 7:00 AM EDT - 7 months ago

LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' Requisition

May 24, 2024, 7:30 AM EDT - 8 months ago

YS Biopharma Announces Name Change to LakeShore Biopharma

May 21, 2024, 4:15 PM EDT - 8 months ago

YS Biopharma Announces Results of Extraordinary General Meeting

May 7, 2024, 4:20 PM EDT - 9 months ago

YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer

Apr 29, 2024, 8:00 AM EDT - 9 months ago

YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

Apr 19, 2024, 9:10 AM EDT - 9 months ago

YS Biopharma Co., Ltd. (YS) Q3 2024 Earnings Call Transcript

Apr 19, 2024, 7:00 AM EDT - 9 months ago

YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024

Apr 18, 2024, 8:00 AM EDT - 9 months ago

YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine

Apr 16, 2024, 8:00 AM EDT - 9 months ago

YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024

Apr 9, 2024, 8:00 AM EDT - 10 months ago

YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine

Apr 3, 2024, 8:00 AM EDT - 10 months ago

YS Biopharma Announces Full Repayment of US$40,000,000 Loan Facility

Mar 5, 2024, 8:00 AM EST - 11 months ago

YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries

Feb 22, 2024, 5:00 PM EST - 11 months ago

YS Biopharma Announces Results of Extraordinary General Meeting held on February 22, 2024

Feb 16, 2024, 8:20 PM EST - 1 year ago

YS Biopharma Announces Results of Extraordinary General Meeting and Responds to False Statements about the Meeting

Feb 16, 2024, 5:36 PM EST - 1 year ago

Shareholders Led by Yi Zhang Announce Successful Results of Removal of Directors and Election of New Directors of YS Biopharma Co., Ltd.

Feb 14, 2024, 8:00 AM EST - 1 year ago

YS Biopharma to Hold an Extraordinary General Meeting on February 22, 2024 pursuant to a Shareholder Requisition to Enhance Corporate Governance

Feb 14, 2024, 7:50 AM EST - 1 year ago

YS Biopharma Announces Appointment of New Directors

Feb 12, 2024, 8:50 AM EST - 1 year ago

YS Biopharma Responds to a Notice of Extraordinary General Meeting of Shareholders of YS Biopharma Co., Ltd.

Feb 9, 2024, 6:30 AM EST - 1 year ago

YS Biopharma Announces US$40 Million Private Placement Financing

Feb 8, 2024, 6:10 PM EST - 1 year ago

Shareholders of YS Biopharma Announce an Extraordinary General Meeting

Jan 22, 2024, 5:00 PM EST - 1 year ago

YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024

Jan 8, 2024, 8:00 AM EST - 1 year ago

YS Biopharma Announces Changes to its Board Committees

Dec 20, 2023, 4:30 PM EST - 1 year ago

YS Biopharma Responds to Unauthorized Press Release Regarding Extraordinary General Meeting

Dec 20, 2023, 8:56 AM EST - 1 year ago

YS Biopharma Co., Ltd. to Hold Extraordinary General Meeting on December 28, 2023

Nov 14, 2023, 8:30 AM EST - 1 year ago

Noble Capital Markets Initiates Coverage on YS Biopharma With Outperform Rating and US$5.25 Price Target

Oct 31, 2023, 8:30 AM EDT - 1 year ago

YS Biopharma Announces Completion of Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine

Oct 26, 2023, 8:30 AM EDT - 1 year ago

YS Biopharma Announces Receipt of Nasdaq Notice

Sep 26, 2023, 8:30 AM EDT - 1 year ago

YS Biopharma Announces First Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine

Sep 15, 2023, 8:30 AM EDT - 1 year ago

YS Biopharma Granted Patent in the U.S. for Immunotherapy Targeting Chronic Hepatitis B Virus Infection

Sep 5, 2023, 8:30 AM EDT - 1 year ago

YS Biopharma to Participate in Participate in Citi's 18th Annual Biopharma Conference

Aug 24, 2023, 4:15 PM EDT - 1 year ago

YS Biopharma Announces Purchase of Shares by Company Officers

Aug 15, 2023, 5:00 PM EDT - 1 year ago

YS Biopharma Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2024

Jul 26, 2023, 5:00 PM EDT - 1 year ago

YS Biopharma Announces Financial Results for Fiscal Year 2023 Ended March 31, 2023

Jul 21, 2023, 4:30 PM EDT - 1 year ago

YS Biopharma to Report Financial Results for Fiscal Year 2023 on July 26, 2023

Jun 1, 2023, 8:30 AM EDT - 1 year ago

YS Biopharma's PIKA Rabies Vaccine Receives Phase 3 Clinical Trial Approval From Philippines FDA

May 26, 2023, 8:56 AM EDT - 1 year ago

Top 5 Health Care Stocks That Could Blast Off In May - Coherus BioSciences (NASDAQ:CHRS), Intercept Pharma (NASDAQ:ICPT)

CHRS ICPT SRDX

May 18, 2023, 8:25 AM EDT - 1 year ago

YS Biopharma to Participate in the Virtual Benchmark Healthcare House Call Conference on May 23, 2023

May 16, 2023, 7:00 AM EDT - 1 year ago

YS Biopharma's PIKA Rabies Vaccine Receives Phase 3 Clinical Trial Approval in Pakistan

Apr 26, 2023, 7:45 AM EDT - 1 year ago

Top 5 Health Care Stocks That Are Preparing To Pump In Q2 - AngioDynamics (NASDAQ:ANGO), Apollomics (NASDAQ:APLM)

ANGO APLM TTOO